Xpress sars-COV-2 tests purchase of systems and assays

Ended Purchase Order Awarded Last action

Contract number
W911QY20P0119
Awardee
Awarding agency
Obligated
$2,149,607

Award facts

Opportunity
Contract value 100% obligated
$2,149,606.95 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Sunnyvale, CA 94089, USA
National interest action
Coronavirus COVID-19

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00004 · Xprsars-COV2-10 tests modification to change contract administration team. $0
Supplemental Agreement for work within scope P00002 · Xprsars-COV2-10 tests modification to adjust clin quantities and DE-obligate unused funds. -$445,867
Supplemental Agreement for work within scope P00003 · Xprsars-COV2-10 tests modification to add funding and establish contract schedule for line item 0003. $445,511
Supplemental Agreement for work within scope P00001 · Xpress sars-COV-2 tests changing quantities and types of systems required. $0
Original award $2,149,962

About this award

The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $2.15 million firm fixed price purchase order to Cepheid, a subsidiary of Danaher Corporation, for the delivery of XPRESS SARS-COV-2 test systems and assays. The contract supports the Army's response to the Coronavirus Disease 2019 (COVID-19) national emergency through the purchase of Cepheid's GeneXpert Systems and tests to rapidly detect the presence of SARS-CoV-2 virus. Performance will occur in Sunnyvale, California over two months from March to May 2020. No subcontractors or set aside designations were identified. The award provides molecular diagnostic capabilities to the Joint PEO Chemical and Biological Defense program's medical and public health missions.

Quick answers

Who was awarded contract W911QY20P0119?

W911QY20P0119 was awarded to Cepheid by ACC Aberdeen Proving Ground (Army Contracting Command) on March 23, 2020.

How much is contract W911QY20P0119 worth?

The government has obligated $2,149,607 on W911QY20P0119.

Which agency awarded contract W911QY20P0119?

ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911QY20P0119, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).

Was contract W911QY20P0119 competed?

The extent of competition for W911QY20P0119 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award